Veracyte (VCYT) Payables (2012 - 2026)

Veracyte (VCYT) has 15 years of Payables data on file, last reported at $6.9 million in Q1 2026.

• Quarterly Payables fell 56.03% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 56.03% YoY) and the FY2025 annual result came in at $4.6 million, down 46.8% from the prior year.
• Payables improved to $6.9 million in Q1 2026 per VCYT's latest filing, from $4.6 million in the prior quarter.
• The five-year high for Payables was $15.7 million in Q1 2025, with the low at $4.6 million in Q4 2025.
• Average Payables over 5 years is $10.9 million, with a median of $11.4 million recorded in 2025.
• Year-over-year, Payables jumped 57.95% in 2022 and sank 56.03% in 2026.
• Veracyte's Payables stood at $11.9 million in 2022, then increased by 8.66% to $12.9 million in 2023, then sank by 33.29% to $8.6 million in 2024, then plunged by 46.8% to $4.6 million in 2025, then jumped by 50.4% to $6.9 million in 2026.
• Business Quant data shows VCYT's Payables at $6.9 million in Q1 2026, $4.6 million in Q4 2025, and $5.5 million in Q3 2025.